FDA
-
-
-
-
-
-
-
Ten-Year Pivotal Data Demonstrate Long-Term Durability of Edwards Lifesciences’ Resilia Tissue
-
-
-
-
-
-
-
FDA approves Edwards SAPIEN M3 as first transseptal mitral valve system
-
-
-
-
-
-
-
Picard Announces Appointment of Two New Members to its Board of Directors
-
-
-
-
-
-
-
Edwards Lifesciences (EW) gains after Boston Scientific (BSX) ends worldwide sales of the ACURATE neo2 and ACURATE Prime
-
-
-
-
-
-
-
Stifel Reiterates Buy Rating on Edwards Lifesciences (EW)
-
-
-
-
-
-
-
Edwards Lifesciences Outlines Growth Strategy at Annual Investor Conference
-
-
-
-
-
-
-
Edwards Lifesciences (EW) shares rally on Evoque FDA approval
-
335,219 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All


